Braskem Approved for Private Equity Fund Investment
Braskem stated in a "relevant fact" notice: "Braskem S.A., continuing the Material Fact of December 23, 2025, hereby informs its shareholders and the market in general that it has learned, through the website of the Administrative Council for Economic Defense, that its General Superintendence issued a Decision approving, without restrictions, the Concentration Act relating to the potential entry of a certain Private Equity Investment Fund, under the specialized consultancy of IG4 Sol Ltda., as a direct and/or indirect shareholder of the Company, assuming the stake currently held by Novonor S.A. - In Judicial Reorganization, as a result of the acquisition, by Shine I Fundo de Investimento em Direitos Creditorios de Responsabilidade Limitada, of existing credits against companies of the Novonor Group, currently secured by fiduciary assignment of Braskem shares."
Trade with 70% Backtested Accuracy
Analyst Views on BAK
About BAK
About the author

- Control Transfer Agreement: Braskem announced that Novonor and NSP Investimentos have signed an agreement to sell control of the company to private equity fund Shine I, managed by IG4 Capital, with completion expected within 30 days, indicating a significant shift in governance structure.
- Shareholders Agreement Upcoming: Within the next 30 days, Shine I and Petrobras are expected to sign a new shareholders' agreement governing Braskem's operations, further solidifying the new investor's control over the company.
- Petrobras Evaluation: Petrobras, which currently owns 47% of Braskem's voting shares and 36.1% of its total shares, is evaluating the terms of the transaction to decide on its waiver rights, which could impact the final outcome of the deal.
- Voting Shares Sale Details: The agreement details the court-supervised sale of approximately 50.1% of Braskem's voting shares and about 34.3% of its total shares, reflecting a significant adjustment in the shareholder structure that may influence future operational strategies and market performance.
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Braskem and its executives have engaged in securities fraud or other unlawful business practices, which could lead to significant losses for investors.
- Capital Structure Optimization: On September 26, 2025, Braskem announced it had retained financial and legal advisors to optimize its capital structure; however, this news caused its ADR price to drop by 14.71%, indicating market concerns about its financial health.
- Deteriorating Financial Performance: On March 26, 2026, Braskem reported widening losses and issued a going-concern warning in its 2025 financial results, further undermining investor confidence.
- ADR Price Volatility: Following the financial report, Braskem's ADR price fell by 10.66% to $3.52 per ADR, reflecting a pessimistic outlook from the market regarding its future prospects.
- Deteriorating Financials: Braskem reported a Q4 net loss of 10.28 billion reais (approximately $1.96 billion), nearly doubling from 5.64 billion reais a year earlier, indicating significant challenges in financial management that could impact future financing capabilities.
- Revenue Decline: The company's Q4 net revenue fell by 7% to 16.1 billion reais, primarily due to tax writedowns, provisions related to the Alagoas salt mine incident, and currency effects, suggesting that while the core business remains intact, external factors have significantly pressured performance.
- Rising Debt: Braskem's adjusted net debt increased to $7.5 billion in Q4, with leverage surging to 14.74x, reflecting severe risks to its debt repayment capacity, potentially forcing the company to seek bankruptcy protection or pursue out-of-court restructuring in the coming months.
- Ongoing Governance Risks: Following multiple failed divestment attempts by controlling shareholder Novonor after Brazil's Carwash corruption scandal, Braskem faces ongoing governance risks, and despite recent rating upgrades, market confidence in its future remains fragile.
- Argan, Inc. Earnings Forecast: Argan, Inc. is expected to report earnings per share of $1.99 for the quarter ending January 31, 2026, reflecting a 10.36% decrease compared to the same quarter last year, indicating volatility in its profitability despite beating expectations in two other quarters over the past year.
- Oxford Industries, Inc. Performance Outlook: Oxford Industries anticipates earnings per share of only $0.05, representing a significant 96.35% decline year-over-year, highlighting severe challenges in the competitive textile industry, although the company has exceeded expectations three times in the past year.
- Veritone, Inc. Earnings Projection: Veritone is forecasting earnings per share of -$0.10, which is a 60.00% increase from the same quarter last year, yet it failed to meet consensus expectations in the first quarter of 2025, reflecting instability in its earnings potential.
- Braskem S.A. Financial Condition: Braskem is projected to report earnings per share of -$0.98, a staggering 151.28% decrease compared to the same quarter last year, indicating ongoing difficulties in the chemical sector, and it missed consensus expectations in the fourth quarter of 2024, underscoring persistent pressure on its profitability.
- Acquisition Approval: Brazil's antitrust authority CADE approved the agreement for IG4 Capital to acquire a controlling stake in Braskem from Novonor, marking a significant milestone in the long-standing dispute over control of the petrochemical company, with the agreement approved without restrictions.
- Shared Control: Under the deal, IG4 will share control of Braskem with oil giant Petrobras, while Novonor retains a 4% stake; the approval will become final in 15 days unless appealed or changed by board members, indicating a stable transition of control.
- Bankruptcy Risk: Braskem is reportedly burning through cash and may need to seek bankruptcy protection within the next 2-3 months, raising concerns about its financial health and potential impacts on stock performance, which could deter investors.
- Market Reaction: The approval from CADE alleviates market concerns regarding the slow progress of the deal, especially as IG4 had considered pulling out, yet Braskem's ongoing financial struggles remain a critical issue for stakeholders to monitor closely.

- Norwegian Bank's Stake Reduction: Norges Bank has reduced its stake in Braskem to 4.96% of class A preferred shares.
- Impact on Braskem: This reduction in ownership may influence Braskem's market dynamics and investor perceptions.










